Genethera Overview

  • Status
  • Public

  • Employees
  • 2

  • Stock Symbol
  • GTHR

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $0.02

  • (As of Thursday Closing)

Genethera General Information


GeneThera Inc is a biotechnology company using its proprietary molecular sciences and technologies dedicated to eradicating diseases such as COVID-19, Paratuberculosis, Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections. It focuses on developing novel molecular diagnostic tests, therapeutics, and vaccines through its proprietary robotic technologies. Its Molecular Robotic/AI Platform and Therapeutic strategy (MORAPAT) is designed to prevent the spread of disease from animals and at the same time, allow better control of zoonotic infectious agents. The company has also developed a molecular system for the detection of Mycobacterium Avian Paratuberculosis in the milk of infected dairy cows.

Contact Information

Formerly Known As
Hand Brand Distribution
Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 7577 West 103rd Avenue
  • Suite 212
  • Westminster, CO 80021
  • United States
+1 (303) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genethera Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $0.02 - $0.09 $818K 34.1M 18.3K -$0.03

Genethera Financials Summary

In Thousands,
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,008 1,828 1,158 280
Revenue 0 0 0 0
EBITDA (930) (1,004) (735) (484)
Net Income (938) (1,011) (774) (518)
Total Assets 4 6 12 21
Total Debt 815 811 812 822
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genethera Executive Team (2)

Name Title Board Seat Contact Info
Tannya Irizarry Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
You’re viewing 1 of 2 executive team members. Get the full list »

Genethera Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genethera Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 25-Jan-2012 0000000000 Other Healthcare Services 0000000 0
Applied Genetics 13-Dec-2006 Joint Venture Other Healthcare Services 0000000 0
To view Genethera’s complete investments and acquisitions history, request access »